Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |